Profound Medical Corp. Common Stock
$5.83
$0.15 (+2.64%)
$5.66Day Range$5.85
Key Statistics
Market Cap
$213.03M
Shares Outstanding
36.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
May 9, 2016
Round Lot
100
Locale
US
Trading Data
Day Open
$5.71
Day High
$5.85
Day Low
$5.66
Volume
76.6K
VWAP
$5.76
Prev Close
$5.68
Transactions
--
Acc. Volume
--
About Profound Medical Corp. Common Stock
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 3841162 employees2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, A6, L4W 5K5647-476-1350IPO May 9, 2016US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001628808
- Composite FIGI
- BBG00CXJY8L7
- Share Class FIGI
- BBG0076T0BS9
- Ticker Root
- PROF
- SIC Code
- 3841
About Profound Medical Corp. Common Stock (PROF) Stock
Profound Medical Corp. Common Stock (PROF) closed the 2026-09-16 session at $5.83, up 2.64% versus the previous close (+0.15). The stock opened at $5.71 and traded between $5.66 and $5.85 during that session. Session trading volume was 77K shares. The volume-weighted average price (VWAP) is $5.76.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
Profound Medical Corp. Common Stock has a market capitalization of $213.0 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. PROF is listed on the XNAS exchange. The company employs approximately 162 people. Profound Medical Corp. Common Stock is headquartered in MISSISSAUGA, A6. The recorded listing date is 2016-05-09.
On this page you can find market PROF stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.